AI Article Synopsis

  • - Lodderomyces elongisporus, first isolated in 1952 and misidentified as Candida parapsilosis, has gained recognition as a significant human pathogen since the 1970s, with its identification solidified through advances in DNA sequencing.
  • - The review outlines the history of L. elongisporus infections, effective treatment strategies, environmental contamination cases, and a critical evaluation of diagnostic methods, including culture-based techniques and molecular tools like ITS-DNA sequencing.
  • - Emphasizing the importance of accurate identification in vulnerable populations, the review calls for more research to create accessible diagnostic tools to improve understanding and patient outcomes for this emerging pathogen.

Article Abstract

Lodderomyces elongisporus, first isolated in 1952, has increasingly been recognized as a significant pathogen, with a notable rise in human infections since the 1970s. Initially misidentified as Candida parapsilosis due to morphological similarities, L. elongisporus has now been conclusively established as a distinct species, largely due to advancements in molecular biology, particularly DNA sequencing. This review traces the detection history of L. elongisporus, from the earliest documented cases to the most recent reports, underscoring its role as a causative agent in human infections. It also explores therapeutic strategies that have demonstrated efficacy, alongside instances of environmental contamination reported in international literature. A critical evaluation of diagnostic methodologies essential for precise identification is provided, including culture-based techniques such as colony morphology on Sabouraud Dextrose Agar (SDA) and chromogenic media, coupled with microscopic assessments using Lactophenol Cotton Blue (LPCB) and Gram staining. The ultrastructure of L. elongisporus, as observed under Scanning Electron Microscopy (SEM), is also discussed. Furthermore, non-culture-based diagnostics, such as sugar utilization tests (API 20C AUX and the innovative in-house arabinose-based "Loddy" test) and antifungal susceptibility profiling, are reviewed, with a particular focus on molecular tools like ITS-DNA sequencing and MALDI-TOF MS, which, despite their higher costs, offer unparalleled specificity. The accurate distinction and characterization of L. elongisporus are paramount, particularly in vulnerable and immunocompromised patients, where misdiagnosis can lead to severe consequences. This review advocates for intensified research efforts to develop more accessible diagnostic tools and deepen our understanding of this emerging pathogen, ultimately aiming to improve patient outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519285PMC
http://dx.doi.org/10.1007/s11046-024-00901-xDOI Listing

Publication Analysis

Top Keywords

lodderomyces elongisporus
8
human infections
8
elongisporus
6
unveiling lodderomyces
4
elongisporus emerging
4
emerging yeast
4
yeast pathogen
4
pathogen holistic
4
holistic approach
4
approach microbiological
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!